More contradicting information:
Under Corporate Update, it states:
"Patrys is entitled to a refund of approximately $2.7 million under the Federal Government’s R&D Tax Incentive Scheme which it expects to receive during 1H FY2024"
but under section 8.6.2, they answer:
"The Company is anticipating a R&D refund to its wholly-owned subsidiary Nucleus Therapeutics Pty Ltd of approximately $2.7 million for the FY23 financial year, and expects to receive this refund before the end of CY 2023...."
So when is the company expected to receive this $2.7m refund, "1H FY2024" or "before end of FY2023" or am I reading this wrong??
This quarterly wreaks of an upcoming CR very, very soon regardless of how the Dr tries to spins this quarterly by using different wording!
Btw, the CDMO should be held accountable for their mess up on the DX1 trial imo!
- Forums
- ASX - By Stock
- Ann: Appendix 4C - Quarterly - 30 June 2023
More contradicting information:Under Corporate Update, it...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAB (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.172M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.3¢ | $10.97K | 3.626M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
41 | 31554019 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 27089307 | 15 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
40 | 31054019 | 0.003 |
24 | 27131332 | 0.002 |
14 | 54551998 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 27089307 | 15 |
0.005 | 11226512 | 10 |
0.006 | 3371450 | 5 |
0.007 | 6601356 | 5 |
0.008 | 1221910 | 4 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |